Scientific program

Scientific program PDF version

Scientific program
28th September 2012 (Friday)
Time Speakers Title
14.00 – 16.00 Registration
16.00 – 16.45 Opening ceremony
16.45 – 17.30 Wacław Szybalski
(McArdle Laboratory, Madison, USA)
Gene therapy in 1962: Transfection of the HPRT gene into human cells
17.30 – 18.00 Seppo Yla-Herttuala
(University of Eastern Finland, Kuopio, Finland), president of the European Society for Gene and Cell Therapy
History of gene therapy
18.00 – 19.00 Get-together cocktail
19.00 – 20.00 Presentations of students and friends of Professor Wacław Szybalski:

  • Ewa Łojkowska (University of Gdansk, Poland), Stanisław KosiedowskiWacław Szybalski: from Lwów to Madison
    – life of scientist and philanthropist
  • Jacek Bigda (Gdansk Medical University, Poland) – Wacław Szybalski for novel immunotherapies
29th September 2012 (Saturday)
09.00 – 09.30 Alain Fischer
(INSERM U768, Paris, France)
13 years of effective gene therapy for primary immunodeficiencies. Where do we stand?
09.30 – 10.00 Adrian Thrasher
(UCL Institute of Child Health, London, UK)
Gene therapies for immunodeficiency diseases
10.00 – 10.30 Seppo Yla-Herttuala
(University of Eastern Finland, Kuopio, Finland)
Gene therapy for cancer and cardiovascular diseases
10.30 – 11.00 Anne Galy
(Genethon, Evry, France)
Development and applications of lentiviral vectors for hematopoietic gene therapy
11.00 – 11.30 Coffee break
11.30 – 12.00 Gustavo Mostoslavsky
(Boston University, Boston, USA)
iPS cells and nuclear reprogramming with factors: another success story by gene therapy
12.00 – 12.30 Alicja Józkowicz
(Jagiellonian University, Krakow, Poland)
Gene and cell therapy
for revascularisation
12.30 – 13.00 Chantal Pichon
(CNRS, Orleans, France)
Deliver and treat with sounds: promises and ongoing challenges for gene transfer
13.00 – 14.00 Lunch
14.00 – 14.30 Patrick Midoux
(CNRS, Orleans, France)
Building up artificial virus for gene therapy: current status and standpoints
14.30 – 15.00 Andrzej Mackiewicz
(Medical University, Poznan, Poland)
Genetic vaccine for cancer treatment
15.00 – 15.30 Claudine Kieda
(CNRS, Orleans, France)
New cell-delivery of anti-cancer gene therapies
15.30 – 16.00 Józef Dulak
(Jagiellonian University, Krakow, Poland)
Gene therapy on demand: site-specific regulation
16.00 End of meeting